Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection.

Sekacheva, Marina; Boroda, Alexander; Fatyanova, Anastasia; Rozhkov, Alexander; Bagmet, Nikolai

Sekacheva, Marina; Boroda, Alexander; Fatyanova, Anastasia; Rozhkov, Alexander; Bagmet, Nikolai.

Afiliación

Sekacheva M; World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia.
Boroda A; World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia.
Fatyanova A; World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia.
Rozhkov A; World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia.
Bagmet N; Department of Biliary, Hepatic, and Pancreatic Surgery, B.V. Petrovsky Russian Scientific Center of Surgery, Moscow, Russia.

Front Oncol ; 13: 1009863, 2023.

Article en En | MEDLINE | ID: mdl-37207139

Palabras clave

CA 15-3; CA-62; CLIA; breast cancer; ductal carcinoma in-situ (DCIS); mammography; screening; tumor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Rusia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google